Drug maker ICN Pharmaceuticals Inc. said Tuesday that the U.S. Food and Drug Administration has approved the company's antifungal medicine Nystatin.
Nystatin is a fungal antibiotic that is used as the active ingredient in a number of prescription anti-fungal medicines. It can be delivered orally, by suppository, or in cream or powder form.
